Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 14, 2010

View Archived Issues

PBT-434 prevents nigral cell death in models of Parkinson's disease

Piramal Life Sciences describes preclinical pharmacology of new insulin sensitizer P-1738

Studies further characterize HIV integrase inhibitor S/GSK-1349572

Multiple studies describe preclinical profile of antibacterial polypeptide NZ-17074

Helix BioPharma completes GLP toxicology studies of L-DOS-47

Roskamp Institute to begin trials of RCP-006 for treatment of Alzheimer's disease

Genmab and Lundbeck to collaborate on human antibodies for CNS disorders

Merck Frosst discovers novel acyl-CoA desaturase inhibitors

Bayer Schering Pharma discovers vasopressin receptor inhibitors

E.U. concerned member states reach positive agreement for approval of Vimovo

Novel GlyT-1 inhibitors synthesized at sanofi-aventis

ArQule and Daiichi Sankyo expand new kinase inhibitor discovery collaboration

Boehringer Ingelheim discloses new FADK 1 inhibitors

Cell Cure Neurosciences receives investments to develop stem cell treatments

SEPS Pharma patents new antifungal fluconazole derivatives

Tesetaxel receives EMA orphan drug status for gastric cancer

EMA approves Twynsta single pill combination for high blood pressure

Pharmalink obtains FDA orphan drug designation for PL-56

Boehringer Ingelheim discontinues flibanserin development

Antisoma provides update in interim management statement

Alexza receives FDA complete response letter for AZ-004 NDA

Genentech begins phase II vismodegib trial in operable basal cell carcinoma

ESMO and Thomson Reuters collaborate on oncology web portal

Encouraging results reported for phase IIb trial of A-3309 in chronic idiopathic constipation

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...